Thursday, November 30, 2023

Supreme Court to hear plea for Public Clinical Trials Data Of Rotavac Vaccine after 3 Weeks

Want create site? Find Free WordPress Themes and plugins.

The Supreme Court has adjourned the hearing in a PIL that seeks publication of segregated date of the clinical trial (phase III) of the vaccine Rotavac administered to infants to protect against diarrhoea.

A bench comprising of Justice AS Bopanna and Justice MM Sundresh heard the petition filed by S Srinavasan in the year 2016 where he seeked publication of the data of the clinical trial of the vaccine against Rotavirus conducted between 2011-2013.

Advocate Prashant Bhushan, appearing on behalf of the petitioner, submitted that the trial data has to be disclosed to the general public as per Helsinki guidelines, 2015, Bioethics Committee, and ICMR guidelines, 2017.

He particularly referred to Helsinki guidelines and quoted “all researchers have ethical obligations with respect to the publication of the results of research. There is a duty to make public research on the human subject and accountability for the accuracy of reports. It must be made publicly available.”

Justice Bopanna asked “But now the vaccine has been tested, used worldwide?”

Prashant Bhushan replied, “In the US, the same Rotavac(vaccine) was introduced in Universal Immunization program but was then withdrawn when it was found to have side effects. Therefore, once trials are over, it has to be released for the scientists to scrutinize”.

Additional Solicitor General Aishwarya Bhati submitted that the issue is covered in Union’s favour by the judgment of the Supreme Court in Dr.Jacob Puliyel case in relation to COVID vaccine.

The bench decided to post the matter after three weeks

Did you find apk for android? You can find new Free Android Games and apps.

News Update